We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Iovance Biotherapeutics Inc | NASDAQ:IOVA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.23 | -2.15% | 10.45 | 10.45 | 10.51 | 10.80 | 10.31 | 10.70 | 4,705,810 | 00:48:17 |
Location: Boston Marriott Copley PlaceDate/Time: Wednesday, March 13, at 8:00 a.m. EDTA live and archived webcast of the presentation will be available by visiting the Investors section of Iovance Biotherapeutics' website at http://ir.iovance.com.
Location: 28 State StreetDate/time: Thursday, March 14, at 3:30 p.m. EDT
Location: The Westin New York Grand CentralDate/Time: Tuesday, March 19, at 8:00 a.m. EDTA live and archived webcast of the presentation will be available by visiting the Investors section of Iovance Biotherapeutics' website at http://ir.iovance.com.
Location: The Metropolitan ClubDate/Time: Thursday, March 21, at 11:25 a.m. EDT
Location: The Ritz-Carlton Shanghai, PudongDate/Time: Thursday, March 28, at 9:00 a.m. China Standard Time (CST)
About Iovance Biotherapeutics, Inc. Iovance Biotherapeutics intends to commercialize autologous cell therapy using tumor-infiltrating lymphocyte (TIL) technology that amplifies the body’s own immune response to eradicate solid tumors or attack blood cancers. The company’s lead candidates are being investigated for the treatment of patients with locally advanced, recurrent or metastatic cancers including melanoma and cervical, head and neck, and non-small cell lung cancer. For more information, please visit www.iovance.com.
Investor Relations Contacts: Annie ChangSolebury Trout646-378-2972achang@troutgroup.com
Chad RubinSolebury Trout646-378-2947crubin@troutgroup.com
Media Relations Contact: Rich AllanSolebury Trout646-378-2958rallan@troutgroup.com
1 Year Iovance Biotherapeutics Chart |
1 Month Iovance Biotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions